Upload
others
View
1
Download
0
Embed Size (px)
Citation preview
7/26/2019
1
Robert C. Holleman, Jr., MDAssociate Professor of Clinical PediatricsPediatric Nephrology and Hypertension
Prisma Health/USC - Midlands
PEDIATRIC HYPERTENSION
2019 SCAAP Meeting
Disclosures
I have no financial or industry relationships to disclose
I will not be discussing any off lable medications
1
2
7/26/2019
2
Pediatric Hypertension
Can we still blame the kidney?
A primary care problem?
Objectives/Questions
How do we define and stage HTN in children and adolescents?
Who should be screened and how often?
What are the most common causes of pediatric HTN?
What is the appropriate diagnostic plan?
When do we treat with medication and what drugs do we choose?
What is the utility of 24hr ambulatory BP monitoring?
Review the 2017 Clinical Practice Guideline
3
4
7/26/2019
3
Pediatrics. 2017;140(3):e20171904
2017 Clinical Practice Guideline
◆ Update to the 2004 “Fourth Report on the Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children and Adolescents.”
◆ 17 member subcommittee◆ Endorsed by the American Heart Association◆ 8 significant changes, 30 key action statements
and 27 additional recommendations published in a 72 page document
Flynn JT et al. Pediatrics. 2017;140(3):e20171904
5
6
7/26/2019
4
2017 Clinical Practice Guideline
1) Replacement of the term “prehypertension” with “elevated blood pressure”
2) New normative BP tables (normal weight children)3) Simplified screening table4) Simplified BP classification for adolescents > 13 yrs5) More limited screening recommendation6) Streamlined evaluation and management strategies7) Expanded role for ambulatory BP monitoring8) Revised recommendation on echocardiography
8 Significant changes:
Flynn JT et al. Pediatrics. 2017;140(3):e20171904
Epidemiology
◆ Overall prevalence of pediatric HTN is 3.5%
◆ Prevalence of elevated BP is 2.2-3.5%
◆ Higher in minority populations
◆ ♂ > ♀
◆ BP BMI
◆ Essential HTN is the most prevalent form
7
8
7/26/2019
5
Epidemiology
◆ Overweight and Obese: 4-25%
◆ Sleep Disordered Breathing: 4-14%
◆ Chronic Kidney Disease: 50%
◆ Preterm Birth/Low Birth Weight: 7%
Increased prevalence in select populations:
Flynn JT et al. Pediatrics. 2017;140(3):e20171904
Epidemiology: Risk Factors
Family History
Low birth weight
Obesity Race
Diet – Na intake
Stress
Smoking Physical Activity
9
10
7/26/2019
6
Blood Pressure Measurement
◆ Cuff size critical◆ Comfort/Cooperation◆ At rest for 3-5 minutes◆ Clothing out of the way◆ Right arm, heart level◆ Back supported, feet on floor◆ At least 2 readings
Patient Issues
Blood Pressure Measurement
◆ Cuff size critical
◆ Calibration and upkeep
◆ Auscultatory
- “Gold standard”
- K1 = SBP, K5 = DBP
◆ Oscillometric
◆ Observer bias
Technical Issues
11
12
7/26/2019
7
◆ Bladder width >40% mid arm circumference
◆ Bladder length 80-100% mid arm circumference
◆ Lower edge of cuff ~2cm above olecranon fossa
◆ For severe obesity, use thigh cuff
How do we define Hypertension?
◆ BP level associated with increased morbidity and mortality
◆ Method of measurement- Casual (office) BP
- 24hr ambulatory BP (BP load)
◆ Large pediatric variation by age, size and sex
◆ Task Force data
13
14
7/26/2019
8
Definition of Hypertension
Designation Kids age 1-12 yearsKids age 13 and
older*
Normal BP < 90th %tile < 120/80
Elevated BP90th%tile to < 95th %tile or
120/<80 to < 95th %tile (whichever is lower)
120/<80 to 129/<80
Stage 1 HTN>95th%tile to <95th%tile + 12
or 130/80 to 139/89 (whichever is lower)
130/80 to 139/89
Stage 2 HTN>95th%tile + 12 or > 140/90
(whichever is lower)> 140/90
*Consistent with American Heart Association and American College of Cardiology guidelines
What is “elevated blood pressure?”
◆ Replaces the term “prehypertension” ◆ BP > 90th %tile but < 95th %tile◆ Adolescents with BP 120-129/75-79◆ Implement healthy lifestyle changes and
identify other cardiovascular disease risk factors
◆ Recheck BP in 6 months◆ If BP remains elevated after 12 months ABPM
is recommended◆ At risk for future HTN so follow up is key
15
16
7/26/2019
9
Diagnosis: Fourth Taskforce
AAP HTN Calculator
https://www.mdcalc.com/aap-pediatric-hypertension-guidelines#next-steps
17
18
7/26/2019
10
AAP HTN Calculator
https://www.mdcalc.com/aap-pediatric-hypertension-guidelines#next-steps
Simplified BP TableAge Boys SBP Boys DBP Girls SBP Girls DBP
1 98 52 98 54
2 100 55 101 58
3 101 58 102 60
4 102 60 103 62
5 103 63 104 64
6 105 66 105 67
7 106 68 106 68
8 107 69 107 69
9 107 70 108 70
10 108 72 109 72
11 110 74 111 74
12 113 75 114 75
>13 120 80 120 80
Based on the 90th %tile BP for age at the 5th
%tile for heightDesigned as a screening tool only
Determines which patients need repeat measurements
Provides a negative predictive value of >99%
19
20
7/26/2019
11
BP Screening: why it’s important
◆ HTN is the most common primary diagnosis in the U.S. with healthcare costs in the billions
◆ High BP in adults is an independent risk factor for the development of cardiovascular disease, stroke, and chronic kidney disease
◆ More than 7 million premature deaths worldwide annually in adults attributable to HTN
◆ HTN accounts for 40% of cardiovascular mortality, more than any other risk factor including smoking
BP Screening: why it’s important◆ BP tracking: childhood BP predicts adult BP
✓ Childhood HTN is the strongest predictor of adult HTN
✓ BP at the 90th %tile in childhood increases risk of adult HTN x 2.4
◆ Childhood HTN is associated with increased carotid intima-media thickness, endothelial dysfunction and increased vascular stiffness markers for adult atherosclerosis
◆ The rationale for childhood BP screening as an important strategy for increasing health and decreasing cardiovascular mortality in adults has been endorsed by:
✓ American Academy of Pediatrics ✓ European Society of Hypertension
✓ American Heart Association ✓ National Heart Lung and Blood Institute
21
22
7/26/2019
12
BP Screening: current practice
Type of Visit 2000-2009 2000-2001 2008-2009
All Visits 35% 26% 41%
Preventive Care Visits 67% 51% 71%
Preventive Care Visits + Overweight/Obese
84% 71% 81%
Hypertension Screening During Ambulatory Pediatric Visits in the United States, 2000-2009
- Shapiro DJ et al, Pediatrics, 2012
Data from the National Ambulatory Medical Care Survey and the National Hospital Ambulatory Medical Care Survey
◆ 93,534 ambulatory visits for children age 3 to 18 sampled◆ BP screening more likely in older kids and kids who were overweight/obese◆ Non factors in screening frequency included: race, gender, region, practice
setting and use of an EMR
Who should be screened and how?
◆ All children > 3 years of age annually
◆ Kids with obesity, kidney disease, diabetes, aortic arch obstruction or coarctation, or those on medications known to increase BP should be screened at ALL office visits
◆ Preferred method is auscultation with an age/size appropriate cuff
◆ If initial BP >90th %tile, take 2 additional readings and average them to determine BP stage
Flynn JT et al. Pediatrics. 2017;140(3):e20171904
23
24
7/26/2019
13
Conditions requiring BP screening prior to age 3 years
◆ History of prematurity (<32 wks), SGA, low birth weight, or complicated NICU stay
◆ Congenital heart, renal, or urologic disease
◆ Recurrent UTIs, hematuria, proteinuria
◆ Solid organ/bone marrow transplant or malignancy
◆ Treatment with drugs known to cause BP
◆ Systemic disease associated with HTN
◆ Evidence of increased intracranial pressure
Flynn JT et al. Pediatrics. 2017;140(3):e20171904
Pathophysiology
Hormonal regulation
Genetics Environment
25
26
7/26/2019
14
Etiology of Pediatric HTN
◆ No identifiable cause
◆ Age > 6 years
◆ Positive family history
◆ Closely related to BMI
◆ Negative history
◆ Stress sensitive
◆ Less severe*
◆ Systolic*
◆ Age < 6 years
◆ Lack of co-morbidities or family history
◆ Signs/symptoms more likely
◆ History suggestive
◆ More severe*
◆ Diastolic*
ESSENTIAL HTN SECONDARY HTN
*Not reliable, a loose association
Obesity related HTN
◆ 35-50% of hypertensive adolescents are obese◆ The relationship between BP and weight begins
as early as age 5yrs◆ HTN is three times more common in obese
children◆ Obesity is an independent risk
factor for other cardiovascular morbidity ● insulin resistance/type II DM● dyslipidemia● LVH
27
28
7/26/2019
15
Obesity related HTN
The Perils of Insulin
SNS
Altered
vascular
reactivity
Na
retention RAS
HYPERTENSION
Renal Causes of Secondary HTN
◆ Parenchymal Disease (70-80%) Reflux nephropathy/scarring Obstructive uropathy
Inherited disease (PKD, TS) Dysplasia/hypoplasia
Chronic glomerular disease
◆ Renovascular Disease (5-10%) RA stenosis (FMD, NF, Williams) RA/RV thrombosis
Vascular malformation (AVM) External compression
◆ Chronic or End Stage Kidney Disease
29
30
7/26/2019
16
Other Causes of Secondary HTN
◆ Cardiovascular Coarctation Vasculitis
◆ Endocrine Catecholamine excess (the “omas”)
Corticosteroid excess (CAH, Cushing, hyperaldo,AME)
Hypercalcemia (Hyperparathyroidism, Williams)
Hyper and hypothyroidism
Other Causes of Secondary HTN◆ Neurologic
Central ( ICP, seizures, spinal cord lesions)
Peripheral (Guillain-Barre, dysautonomia)
◆ Drugs Caffeine Nicotine
Steroids Decongestants
Cocaine Methamphetamine
-agonists ADHD meds
OCPs
31
32
7/26/2019
17
Most Common Causes By Age
◆ RA thrombosis
◆ RV thrombosis
◆ Congenital uropathy
◆ Coarctation
◆ RA stenosis
◆ BPD
◆ Renal parenchymal dz
◆ RA stenosis
◆ Coarctation
◆ Medications
◆ Endocrine causes
◆ Essential HTN
Decreasing frequency
NEONATE FIRST 6 YEARS
Most Common Causes By Age
◆ Renal parenchymal dz
◆ Essential HTN
◆ RA stenosis
◆ Endocrine causes
◆ Essential HTN
◆ Renal parenchymal dz
◆ Substance abuse
◆ Teen prednancy
◆ Endocrine causes
Decreasing frequency
6-10 YEARS ADOLESCENCE
33
34
7/26/2019
18
Primary vs Secondary HTN
Adapted from Flynn, J. Pediatr Nephrol, Vol 28, 2013
Genetic HTN can be more than just “essential” disease
◆ Advances in positional cloning have led to the identification of specific monogenic forms of HTN
◆ Suspect in kids with difficult to control HTN and a strong family history of early onset severe HTN or those with K+ abnormalities
35
36
7/26/2019
19
Monogenic Forms of HTN
◆ Glucocorticoid-remediable aldosteronism
AD; chromosome 8; K+; renin; aldo
◆ Apparent mineralocorticoid excess
AR; chromosome 16; K+; renin; aldo
◆ Liddle syndrome
AD; chromosome 16; K+; renin; aldo
◆ Gordon syndrome (pseudohypoaldo type II)
AD; chromosomes 1, 17, and 12; K+; renin
Evaluating the Hypertensive Child
◆ Is the HTN real and sustained?
◆ Is there a definable cause or a clue to secondary disease?
◆ Are there other cardiovascular risk factors?
Consider the following questions:
37
38
7/26/2019
20
Step 1 ➢ History
◆ Perinatal complications including prematurity/birth weight
◆ UTIs or voiding dysfunction
◆ Sleep disturbances
◆ Nutrition and physical activity
◆ Growth and development
◆ Medications/Drugs
◆ Psychosocial history
◆ Complete ROS
◆ Complete family history
Hypertensive symptoms
Most pediatric patients with hypertension are asymptomatic
39
40
7/26/2019
21
Meds and Drugs Associated with Elevated BP
◆ Over the Counter Drugs◆ Decongestants, Caffeine, NSAIDs, Herbal and
Nutritional supplements
◆ Prescription Drugs◆ ADHD medications
◆ Contraceptives
◆ Steroids
◆ TCAs
◆ Illicit Drugs◆ Cocaine
◆ Amphetamines/Methamphetamines
Step 2 ➢ Physical Exam
◆ Growth curve, BMI
◆ Other vital signs
◆ Dysmorphic features
◆ Fundoscopic changes
◆ Skin findings – striae, neurocutaneous or vasculitic lesions, acanthosis
◆ Genitalia – ambiguous, virilized
◆ Peripheral pulses, LE BPs, bruits
41
42
7/26/2019
22
Step 3 ➢ Staged Work UP
◆ Blood work◆ Chemistry Panel and lipid profile
◆ Based on BMI/risks consider HgbA1c and LFTs
◆ Urinalysis
◆ Renal Ultrasound◆ If <6yrs, history of prematurity or UTIs, or abnormal
U/A or renal function
◆ ECHO◆ Recommended at time of consideration of drug tx
PHASE 1
Staged Work Up
◆ Further imaging based on phase 1 work up◆ VCUG, MRA/CTA, Angiography
◆ Urine Pro:Cr or 24hr urine protein◆ Urine Drug Screen◆ Thyroid function tests◆ Renin*, Aldosterone*◆ Plasma and urine steroids
PHASE 2 – if indicated
* Consider in phase 1 if high suspicion of 2º HTN, infant/toddler, or if abnormal electrolytes
43
44
7/26/2019
23
Cardiac Diagnostics◆ Prevalence of left ventricular hypertrophy (LVH) in
childhood hypertension is 30-40%◆ HTN LVH Adverse CVD Outcomes◆ EKG is NOT recommended◆ ECHO should be done at time of initiation of
medication◆ ECHO should be repeated every 6-12 months for
kids with documented LVH or poorly controlled HTN with normal initial ECHO
◆ LVH is defined as:◆ LV mass index > 51g/m2.7 for all kids > 8yrs◆ LV mass > 115g/BSA boys, > 95g/BSA girls
The Therapeutic Plan
Non-pharmacologic tx Good for everyone
Multifaceted
AntihypertensivesWho gets them?
Which ones?
45
46
7/26/2019
24
Goals of Therapy
◆ Reduce the risk of target organ damage◆ Reduce the risk of adult HTN and CVD◆ Achieve optimal BP control
◆ Target BP < 90th %tile for younger children◆ Target BP <130/80 for adolescents > 13 yrs
Non-pharmacologic therapy“TLC”
Wt Loss
Lifestylemodification
Stressmanagement
Exercise
Diet
Blood Pressure
47
48
7/26/2019
25
Dietary Interventions◆ Na+ restriction (< 2 gm/day)
greater “salt sensitivity” in African Americans and obese pts
◆ Dietary Approaches to Stop HTN or “DASH” more fruits, veggies, whole grains, low fat dairy
theoretical benefit from K+, Ca++, and Mg++
◆ Avoid caffeine/energy drinks
◆ Address dietary cholesterol and fat as well as foods with high glycemic load when appropriate
49
50
7/26/2019
26
The Salt Dilemma◆ Difficulty controlling sodium content of
meals outside the home
◆ Difficultly interpreting nutrition labels
◆ Difficulty identifying suitable low Na snacks
◆ Resources often limited
◆ Recommended daily intake:◆ 1-3 years < 1000mg
◆ 4-8 years < 1200mg
◆ Older kids < 1500mg
Fast Food◆ It’s not just fast…its cheap, convenient and without
portion control
◆ Extremely high in sodium
◆ McDonald’s◆ Grilled Chicken Classic 1240mg
◆ Chicken McNuggets 670mg
◆ Pizza Hut◆ 12” thin crust cheese pizza 490mg
◆ KFC◆ Oven Roasted Twister 1390mg
◆ Subway◆ 6” Ham sub 1280mg
51
52
7/26/2019
27
Benefits of the “other salts”
◆ Potassium, magnesium and calcium have a beneficial effect on BP
◆ Potassium leads to suppression of renin
The Benefits of Exercise
◆ sympathetic tone and SVR
◆ Contributes to weight loss
◆ Lowers insulin levels
◆ 30-60 min daily of moderate to strenuous activity
◆ For most kids with HTN…”it’s ok to play”
Lowers blood pressure
53
54
7/26/2019
28
Treatment PlanRisk Assessment
◆ Family History:
- HTN, CVD, CVA
◆ Obesity
◆ Dyslipidemia
◆ Insulin resistance
◆ LVH
◆ Proteinuria or microalbuminuria
◆ Chronic disease:- DM, CKD
Co-Morbid Risk Factors
Target Organ Dz (TOD) Chronic Disease
Treatment PlanIndications to Rx
◆ Stage 1 HTN that has failed lifestyle change after 3-6 months
◆ Stage 2 HTN
◆ Symptomatic HTN
◆ Presence of end organ damage
◆ Kids with chronic disease (DM, CKD)
55
56
7/26/2019
29
Drug Therapy - Choices
◆ ACE inhibitors
◆ Ca channel blockers
◆ Diuretics
◆ Angiotensin receptor blockers (ARBs)
◆ Sympathetic antagonists - and/or
◆ Other
Angiotensin Converting Enzyme Inhibitors (ACEI)
◆ Mechanism: Ang I Ang II
◆ Adverse effects: cough, hypotension, GFR, angioedema, K+, marrow suppression
◆ Contraindications: pregnancy, AKI, bilateral renal artery stenosis, volume depletion
◆ The “prils”: enalapril, lisinopril, captopril
◆ Benefits: very effective, well tolerated, reno-protective, proteinuria
◆ Other: some resistance in African Americans
57
58
7/26/2019
30
Ca Channel Blockers
◆ Mechanism: block influx of Ca++ into vascular smooth muscle cells ➢ decrease vascular resistance
◆ Adverse effects: HA, flushing, hypotension, edema, gingival hypertrophy
◆ Short acting: safe when used with caution, isradipine vs. nifedipine
◆ Long acting: amlodipine, nifedipine XL◆ Benefits: good peds experience, well
tolerated, convenient dosing forms available
Diuretics
◆ Mechanism: block renal solute reabsorption ➢ decreased IV volume
◆ Adverse effects: K, Na, alkalosis, enuresis, hyperlipidemia, hypercalciuria, hyperglycemia
◆ Diverse group of drugs: THIAZIDES #1 for chronic HTN; useful as 2nd agent or occasionally as monotherapy; Chlorothiazide, HCTZ LOOP agents acute HTN in certain settings, refractory volume overload; Furosemide, Bumetanide K+ SPARING weak diuretics; use for mineralocorticoid excess or as 2nd diuretic if hypoK; Spironolactone, Amiloride
59
60
7/26/2019
31
Angiotensin Receptor Blockers
◆ Mechanism: Prevents binding of ang II to the type I receptor (vascular smooth muscle and adrenal gland) ➢
vasoconstriction aldosterone◆ Adverse effects: same as ACEI except
cough◆ Contraindications: same as ACEI◆ The “tans”: Losartan, Irbesartan, Valsartan◆ General: less pediatric experience;
adjunctive antiproteinuric effect with ACEI
Other Drugs
◆ Beta blockers
◆ Alpha blockers
◆ Clonidine
◆ Hydralazine
◆ Minoxidil
These drugs are NOT first line agents
61
62
7/26/2019
32
Remember these drugs…
Amlodipine Enalapril
Starting dose 0.1mg/kg (max 5mg) 0.1mg/kg (max 5mg)
Interval Daily - BID Daily -BID
Suspension 1mg/ml 1mg/ml
Tablet strength 2.5, 5, 10 2.5, 5, 10, 20
Drug Therapy Strategies◆ If therapy needed in young child prior to
completion of work-up
Ca channel blocker◆ For patients with proteinuria, renal dz or
diabetes, or evidence of renovascularhypertension
ACE Inhibitor◆ Partially controlled BP on good dose Ca channel
blocker or ACEI
HCTZ
63
64
7/26/2019
33
Therapy Take Home Points◆ Ca channel blockers are generally the safest
choice when dosed appropriately
◆ ACEIs are not to be feared and have additional benefits
◆ Diuretics are making a comeback in pediatrics particularly in salt sensitive essential disease
◆ -blockers have more side effects and should be reserved for difficult to control HTN
BP Monitoring
Medication prescribed?
Follow q 4-6 weeks until goal
BP achieved
Follow q 3-4 months
Follow q 3-6 months
Yes No
Then
Assess compliance at every visit
DietExercise
Medications
65
66
7/26/2019
34
Hypertension and the Athlete
◆ Though existing guidelines have conflicting recommendations, there is no evidence that exercising while hypertensive increases risk of sudden death
◆ Physical fitness is associated with lower BP and lower all cause mortality
◆ More caution attached to high static sports: weight lifting, boxing, wrestling
Flynn JT et al. Pediatrics. 2017;140(3):e20171904
Hypertension and the Athlete
◆ Prior to participation in competitive sports, children and adolescents with HTN should be assessed for target organ effects and risk
◆ Children and adolescents with HTN should have a BP below stage 2 cutoffs before participating
◆ Hypertensive children and adolescents with LVH should refrain from competitive sports until BP normalized
Flynn JT et al. Pediatrics. 2017;140(3):e20171904
67
68
7/26/2019
35
24hr Ambulatory BP Monitoring
◆ More accurate assessment of blood pressure
◆ Identifies “white coat HTN” saving $$ in work-up
◆ BP readings q 20-30 min
◆ Assess nocturnal dipping
◆ HTN determined by % of readings > 95th %tile or the “blood pressure load”
69
70
7/26/2019
36
Ambulatory BP Monitoring◆ Results track better than casual readings ➢
better predictor of adult HTN
◆ Results better predict the presence of TOD
◆ Loss or blunting of nocturnal dipping correlates with microalbuminuria in kids with normal daytime casual BP and is early indicator of HTN
◆ BP load < 25% considered normal; load > 40% indicates HTN
◆ Estimated that up to 50% of kids with elevated office BP have white coat HTN
Masked Hypertension
◆ Normal office readings with abnormal ABPM
◆ Prevalence as high as 5-6% in unselected pediatric population
◆ Growing evidence of significant risk for target organ disease
◆ High risk groups include: obesity, CKD, and repaired coarctation
71
72
7/26/2019
37
There’s an App For That!
MyTherapy BP Companion
Pediatric Nephrology Program University of S.C. School of Medicine
73
74